Clinical Trials Browser

Lymphoma × durvalumab × 1 year × Clear all

NCT03739931 2025-08-15

Dose Escalation Study of mRNA-2752 for Intratumoral Injection to Participants in Advanced Malignancies

Phase 1 Completed

Head & NeckLymphoid

Squamous Cell Carcinoma of Head and Neck, Lymphoma